It suggests that amyloid deposition is the initial causative event in a cascade of symptoms resulting in neurodegeneration and cognitive decline [8], which was based on the initial discovery of APP mutations as the cause of familial early-onset AD, leading to a central dogma that has guided research in AD for many years. The gene discussed is APP; the disease is Alzheimer disease.